论文部分内容阅读
肝癌肝动脉碘油抗癌药化疗栓塞为肝癌主要的姑息治疗方法之一,而子灶常成为栓后肿 瘤复发的因素。本文搜集69例肝癌肝动脉碘油抗癌药化疗栓塞后有CT随访复查的病例,对子灶栓前、栓后CT检出的能力及子灶碘油潴留的动态变化进行观察分析。 材料与方法 本组69例,44例为经皮股动脉插管肝动脉碘油抗癌药乳剂化疗栓塞的病例,25例为术中肝动脉插管碘油抗癌药乳剂化疗栓塞的病例。术后CT随访1～4次,69例共123次,随访时间2天～4年。60例中男63例,女6例,年龄29～65岁,平均50岁。69例中经病理证
Hepatocellular carcinoma Hepatic arterial iodized oil Anticancer drugs Chemoembolization is one of the main palliative treatment methods for liver cancer, and the sub-foci often become the recurrence factor of tumor after thrombus injection. This article collected 69 cases of hepatocellular carcinoma hepatic arterial lipiodol after chemotherapy embolization CT follow-up review of the case, the sub-supply before and after suppository CT detection of the ability and sub-focal iodized oil retention dynamic changes observed and analyzed. Materials and Methods In this group 69 cases, 44 cases of transfemoral femoral artery catheterization of hepatic artery lipiodol anticancer drug chemoembolization embolization cases, 25 cases of intraoperative hepatic artery catheter iodized oil anticancer drug emulsion chemoembolization cases. Postoperative CT follow-up 1 to 4 times, a total of 123 cases of 69 cases, followed up for 2 days to 4 years. In 60 cases, there were 63 males and 6 females, aged 29-65 years, with an average age of 50 years. Pathology of 69 cases